Chemotherapy and radical radiotherapy for patients with inoperable NSCLC aged 70 and over with inoperable NSCLC-results of a treatment policy based on stage performance status at presentation

被引：0
|
作者：
Maguire, J [1 ]
Kelly, V [1 ]
Smith, N [1 ]
Smyth, C [1 ]
Ledson, M [1 ]
Walshaw, M [1 ]
机构：
[1] Ctr Cardiothorac, Liverpool Lung Canc Unit, Liverpool, Merseyside, England
来源：
THORAX | 2003年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 29 条
  • [1] Intensity-modulated stereotactic radiotherapy for the treatment of medically inoperable patients with NSCLC stage I
    Laechelti, Stephan
    Alber, Markus
    Soehn, Matthias
    Bamberg, Michael
    Steger, Volker
    Weinmann, Martin
    ONCOLOGY REPORTS, 2012, 28 (04) : 1309 - 1314
  • [2] Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment
    Kaesmann, Lukas
    Taugner, Julian
    Eze, Chukwuka
    Roengvoraphoj, Olarn
    Dantes, Maurice
    Gennen, Kathrin
    Karin, Monika
    Petrukhnov, Oleg
    Tufman, Amanda
    Belka, Claus
    Manapov, Farkhad
    ANTICANCER RESEARCH, 2019, 39 (09) : 5077 - 5081
  • [3] The Influence of the ECOG Performance Status and its Change on Overall Survival in the Multimodal Treatment of Patients with inoperable NSCLC in Stage III
    Kaesmann, L.
    Taugner, J.
    Eze, C.
    Dantes, M.
    Roengvoraphoj, O.
    Gennen, K.
    Karin, M.
    Tufman, A.
    Belka, C.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S142 - S142
  • [4] Concurrent chemoradiation using cisplatinum, vinorelbine, and radical radiotherapy with 20 fractions in 4 weeks for patients with inoperable NSCLC and good performance status
    Maguire, J
    Smith, N
    Kelly, V
    Smyth, C
    Ledson, M
    Walshaw, M
    THORAX, 2004, 59 : 52 - 52
  • [5] The role of patient performance status and its changes before and after completion of multimodal treatment for inoperable stage III NSCLC
    Kaesmann, L.
    Taugner, J.
    Eze, C.
    Roengvoraphoj, O.
    Dantes, M.
    Gennen, K.
    Karin, M.
    Tufman, A.
    Belka, C.
    Manapov, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 36 - 36
  • [6] Analysis of (Salvage-) Treatment of First Relapse in Patients with primary inoperable NSCLC in Stage III after initial Radio Chemotherapy
    Eze, C.
    Taugner, J.
    Roengvoraphoj, O.
    Schmidt-Hegemann, N. -S
    Dantes, M.
    Kaesmann, L.
    Belka, C.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S141 - S142
  • [7] Stereotactic Radiotherapy (SIRT) in medically inoperable Patients with NSCLC U1CC Stage I/IIA: Results and Toxicity in a retrospective Case Series
    Gerum, S.
    Manapov, F.
    Niyazi, M.
    Belka, C.
    Ganswindt, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S64 - S64
  • [8] Concurrent weekly gemcitabine (GEM) plus chest radiotherapy (RT) in the treatment of patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Shehata, S
    Karim, SA
    Zaki, T
    Kamel, YM
    LUNG CANCER, 2005, 49 : S392 - S393
  • [9] A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC)
    Liao, Z
    Komaki, R
    Milas, L
    Chen, Y
    Kies, M
    Chang, J
    Jeter, M
    Guerrero, T
    Blumenschein, G
    Cox, J
    LUNG CANCER, 2005, 49 : S372 - S372
  • [10] Preliminary results with hypofractionated radiation therapy (HRT) alone as the curative treatment for patients with early stage, medically inoperable non-small cell lung cancer (NSCLC)
    Faria, S
    Souhami, L
    Duclos, M
    Portelance, L
    Guerra, J
    Devic, S
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S21 - S21
123